Dr. Sandler is Professor and Senior Associate Chair of the Department of Radiation Oncology and Professor of Urology at the University of Michigan Medical School.

He is the principal investigator of a national Radiation Therapy Oncology Group (RTOG) protocol studying radiotherapy and chemotherapy for prostate cancer and is the principal investigator of a National Institutes of Health-funded clinical trial grant investigating novel technological aspects of prostate cancer irradiation. 

Dr. Sandler also is the chair of the Genitourinary Cancer Committee of the RTOG.  He is an active clinical trial scientist and has used an extensive prostate cancer database to study the role of radiation therapy in the treatment of prostate cancer.

His clinical interests include prostate and genito-urinary tumors, genito-urinary radiosurgery, non-melanoma skin cancer, and pediatric central nervous system tumors.

He obtained his degree in medicine at the University of Connecticut, where he also received an MS in physics.  Dr. Sandler was trained in radiation oncology at the University of Pennsylvania.